Our study proposes a molecular mechanism by which PTBP1 promotes endometrial cancer progression by suppressing ferroptosis​​, suggesting that PTBP1 may be a promising therapeutic target for endometrial cancer. The gene discussed is PTBP1; the disease is endometrial cancer.